1. Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study. (2nd November 2021) Authors: Gehin, JE; Warren, DJ; Syversen, SW; Lie, E; Sexton, J; Loli, L; Wierød, A; Bjøro, T; Kvien, TK; Bolstad, N; Goll, GL Journal: Scandinavian journal of rheumatology Issue: Volume 50:Number 6(2021) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗